RIPK1和肌萎缩侧索硬化症研究进展
Research Progress of RIPK1 and Amyotrophic Lateral Sclerosis
DOI: 10.12677/ACM.2023.133610, PDF,   
作者: 袁如意：三峡大学基础医学院，湖北 宜昌；三峡大学人民医院神经内科，湖北 宜昌
关键词: RIPK1；肌萎缩侧索硬化症；程序性坏死；RIPK1； Amyotrophic Lateral Sclerosis； Necroptosis
摘要: 肌萎缩侧索硬化症(Amyotrophic lateral sclerosis, ALS)是一种慢性进展的致死性疾病，受体相互作用蛋白激酶1 (Receptor-interacting protein kinase 1, RIPK1)可能是治疗ALS的关键靶点。在RIPK1介导的程序性坏死中，RIPK1的激活主要受其泛素化和磷酸化调节，其中K63泛素化和M1泛素化及其下游的磷酸化决定是否激活RIPK1以介导细胞生存或死亡。在RIPK1介导的炎症中，RIPK1通过介导炎症基因的表达或者炎症因子的转录直接促进炎症的发生，或者通过调控小胶质细胞来介导脊髓炎症微环境。因此，RIPK1可能是ALS发病关键因素。目前已有用于治疗ALS的RIPK1抑制剂进入临床试验，但是其在炎症性疾病的进一步研究中发现疗效欠佳。最近研究发现在SOD1G93A小鼠中遗传失活RIPK1并不会改善其病理和临床表现，这为以RIPK1为靶点治疗ALS提供了不同的见解。
Abstract: Amyotrophic lateral sclerosis (ALS) is a chronic progressive fatal disease, and receptor-interacting protein kinase 1 (RIPK1) may be a key target for the treatment of ALS. In RIPK1-mediated pro-grammed necrosis, the activation of RIPK1 is mainly regulated by its ubiquitination and phos-phorylation. K63 ubiquitination and M1 ubiquitination and their downstream phosphorylation determine whether RIPK1 is activated to mediate cell survival or death. In RIPK1-mediated in-flammation, RIPK1 directly promotes the occurrence of inflammation by mediating the expression of inflammatory genes or the transcription of inflammatory factors, or mediates the spinal cord inflammatory microenvironment by regulating microglia. Therefore, RIPK1 is a key factor in the pathogenesis of ALS. At present, RIPK1 inhibitor used to treat ALS has entered clinical trials, but it was found to be less effective in further research on inflammatory diseases. Recent studies have found that genetic inactivation of RIPK1 in SOD1G93A mice does not improve its pathological and clinical manifestations, which may be the reason for the lack of efficacy of RIPK1 inhibitors in clinical trials.
文章引用：袁如意. RIPK1和肌萎缩侧索硬化症研究进展[J]. 临床医学进展, 2023, 13(3): 4253-4258. https://doi.org/10.12677/ACM.2023.133610

参考文献

[1] Yuan, J., Amin, P. and Ofengeim, D. (2019) Necroptosis and RIPK1-Mediated Neuroinflammation in CNS Diseases. Nature Reviews Neuroscience, 20, 19-33. [Google Scholar] [CrossRef] [PubMed]
[2] Li, W., Shan, B., Zou, C., et al. (2022) Nuclear RIPK1 Promotes Chromatin Remodeling to Mediate Inflammatory Response. Cell Research, 32, 621-637. [Google Scholar] [CrossRef] [PubMed]
[3] Mifflin, L., Hu, Z., Dufort, C., et al. (2021) A RIPK1-Regulated Inflammatory Microglial State in Amyotrophic Lateral Sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 118, e2025102118. [Google Scholar] [CrossRef] [PubMed]
[4] Degterev, A., Ofengeim, D. and Yuan, J. (2019) Targeting RIPK1 for the Treatment of Human Diseases. Proceedings of the National Academy of Sciences of the United States of America, 116, 9714-9722. [Google Scholar] [CrossRef] [PubMed]
[5] Najjar, M., Saleh, D., Zelic, M., et al. (2016) RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-Like Receptor 4. Immunity, 45, 46-59. [Google Scholar] [CrossRef] [PubMed]
[6] Ito, Y., Ofengeim, D., Najafov, A., et al. (2016) RIPK1 Medi-ates Axonal Degeneration by Promoting Inflammation and Necroptosis in ALS. Science, 353, 603-608. [Google Scholar] [CrossRef] [PubMed]
[7] Varfolomeev, E. and Vucic, D. (2018) Intracellular Regulation of TNF Activity in Health and Disease. Cytokine, 101, 26-32. [Google Scholar] [CrossRef] [PubMed]
[8] Chen, Z.J. (2012) Ubiquitination in Signaling to and Activation of IKK. Immunological Reviews, 246, 95-106. [Google Scholar] [CrossRef] 
[9] Shan, B., Pan, H., Najafov, A., et al. (2018) Necroptosis in Development and Diseases. Genes & Development, 32, 327-340. [Google Scholar] [CrossRef] [PubMed]
[10] Micheau, O. and Tschopp, J. (2003) Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes. Cell, 114, 181-190. [Google Scholar] [CrossRef] 
[11] Bertrand, M.J., Milutinovic, S., Dickson, K.M., et al. (2008) cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases That Promote RIP1 Ubiquitination. Molecular Cell, 30, 689-700. [Google Scholar] [CrossRef] [PubMed]
[12] Wei, R., Xu, L.W., Liu, J., et al. (2017) SPATA2 Regulates the Activation of RIPK1 by Modulating Linear Ubiquitination. Genes & Development, 31, 1162-1176. [Google Scholar] [CrossRef] [PubMed]
[13] Kanayama, A., Seth, R.B., Sun, L., et al. (2004) TAB2 and TAB3 Activate the NF-kappaB Pathway through Binding to Polyubiquitin Chains. Molecular Cell, 15, 535-548. [Google Scholar] [CrossRef] [PubMed]
[14] Geng, J., Ito, Y., Shi, L., et al. (2017) Regulation of RIPK1 Activation by TAK1-Mediated Phosphorylation Dictates Apoptosis and Necroptosis. Nature Communications, 8, 359. [Google Scholar] [CrossRef] [PubMed]
[15] Jaco, I., Annibaldi, A., Lalaoui, N., et al. (2017) MK2 Phos-phorylates RIPK1 to Prevent TNF-Induced Cell Death. Molecular Cell, 66, 698-710. [Google Scholar] [CrossRef] [PubMed]
[16] Dondelinger, Y., Jouan-Lanhouet, S., Divert, T., et al. (2015) NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling. Molecular Cell, 60, 63-76. [Google Scholar] [CrossRef] [PubMed]
[17] Wang, X., Kuang, N., Chen, Y., et al. (2021) Transplantation of Olfactory Ensheathing Cells Promotes the Therapeutic Effect of Neural Stem Cells on Spinal Cord Injury by Inhibiting Necrioptosis. Aging (Albany NY), 13, 9056-9070. [Google Scholar] [CrossRef] [PubMed]
[18] Gerlach, B., Cordier, S.M., Schmukle, A.C., et al. (2011) Linear Ubiquitination Prevents Inflammation and Regulates Immune Signalling. Nature, 471, 591-596. [Google Scholar] [CrossRef] [PubMed]
[19] Ikeda, F., Deribe, Y.L., Skånland, S.S., et al. (2011) SHARPIN Forms a Linear Ubiquitin Ligase Complex Regulating NF-κB Activity and Apoptosis. Nature, 471, 637-641. [Google Scholar] [CrossRef] [PubMed]
[20] Haas, T.L., Emmerich, C.H., Gerlach, B., et al. (2009) Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction. Molecular Cell, 36, 831-844. [Google Scholar] [CrossRef] [PubMed]
[21] Elliott, P.R., Leske, D., Hrdinka, M., et al. (2016) SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. Molecular Cell, 63, 990-1005. [Google Scholar] [CrossRef] [PubMed]
[22] Rahighi, S., Ikeda, F., Kawasaki, M., et al. (2009) Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-kappaB Activation. Cell, 136, 1098-1109. [Google Scholar] [CrossRef] [PubMed]
[23] Hadian, K., Griesbach, R.A., Dornauer, S., et al. (2011) NF-κB Essential Modulator (NEMO) Interaction with Linear and lys-63 Ubiquitin Chains Contributes to NF-κB Activation. Journal of Biological Chemistry, 286, 26107-26117. [Google Scholar] [CrossRef] 
[24] Nanda, S.K., Venigalla, R.K., Ordureau, A., et al. (2011) Polyubiquitin Binding to ABIN1 Is Required to Prevent Autoimmunity. Journal of Experimental Medicine, 208, 1215-1228. [Google Scholar] [CrossRef] [PubMed]
[25] Xu, D., Jin, T., Zhu, H., et al. (2018) TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging. Cell, 174, 1477-1491. [Google Scholar] [CrossRef] [PubMed]
[26] Zhu, K., Liang, W., Ma, Z., et al. (2018) Necroptosis Promotes Cell-Autonomous Activation of Proinflammatory Cytokine gene Expression. Cell Death & Disease, 9, 500. [Google Scholar] [CrossRef] [PubMed]
[27] Christofferson, D.E., Li, Y., Hitomi, J., et al. (2012) A Novel Role for RIP1 Kinase in Mediating TNFα Production. Cell Death & Disease, 3, e320. [Google Scholar] [CrossRef] [PubMed]
[28] McNamara, C.R., Ahuja, R., Osafo-Addo, A.D., et al. (2013) Akt Regulates TNFα Synthesis Downstream of RIP1 Kinase Activation during Necroptosis. PLOS ONE, 8, e56576. [Google Scholar] [CrossRef] [PubMed]
[29] Saleh, D., Najjar, M., Zelic, M., et al. (2017) Kinase Activities of RIPK1 and RIPK3 Can Direct IFN-β Synthesis Induced by Lipopolysaccharide. The Journal of Immunology, 198, 4435-4447. [Google Scholar] [CrossRef] [PubMed]
[30] Feldman, E.L., Goutman, S.A., Petri, S., et al. (2022) Amyotrophic Lateral Sclerosis. The Lancet, 400, 1363-1380. [Google Scholar] [CrossRef] 
[31] Lafont, E., Draber, P., Rieser, E., et al. (2018) TBK1 and IKKε Prevent TNF-Induced Cell Death by RIPK1 Phosphorylation. Nature Cell Biology, 20, 1389-1399. [Google Scholar] [CrossRef] [PubMed]
[32] Weisel, K., Scott, N., Berger, S., et al. (2021) A Randomised, Placebo-Controlled Study of RIPK1 Inhibitor GSK2982772 in Patients with Active Ulcerative Colitis. BMJ Open Gas-troenterology, 8, e000680. [Google Scholar] [CrossRef] [PubMed]
[33] Weisel, K., Berger, S., Thorn, K., et al. (2021) A Randomized, Placebo-Controlled Experimental Medicine Study of RIPK1 Inhibitor GSK2982772 in Patients with Moderate to Severe Rheumatoid Arthritis. Arthritis Research & Therapy, 23, 85. [Google Scholar] [CrossRef] [PubMed]
[34] Weisel, K., Scott, N.E., Tompson, D.J., et al. (2017) Random-ized Clinical Study of Safety, Pharmacokinetics, and Pharmacodynamics of RIPK1 Inhibitor GSK2982772 in Healthy Volunteers. Pharmacology Research & Perspectives, 5, e00365. [Google Scholar] [CrossRef] [PubMed]
[35] Vissers, M., Heuberger, J., Groeneveld, G.J., et al. (2022) Safety, Pharmacokinetics and Target Engagement of Novel RIPK1 Inhibitor SAR443060 (DNL747) for Neurodegenerative Disorders: Randomized, Placebo-Controlled, Double-Blind Phase I/Ib Studies in Healthy Subjects and Patients. Clinical and Translational Science, 15, 2010-2023. [Google Scholar] [CrossRef] [PubMed]
[36] Wang, T., Perera, N.D., Chiam, M., et al. (2020) Necroptosis Is Dispensable for Motor Neuron Degeneration in a Mouse Model of ALS. Cell Death & Differentiation, 27, 1728-1739. [Google Scholar] [CrossRef] [PubMed]
[37] Dominguez, S., Varfolomeev, E., Brendza, R., et al. (2021) Ge-netic Inactivation of RIP1 Kinase Does Not Ameliorate Disease in a Mouse Model of ALS. Cell Death & Differentiation, 28, 915-931. [Google Scholar] [CrossRef] [PubMed]

为你推荐